ANALISIS KADAR INTERLEUKIN-12, INTERLEUKIN-4, CXCL10 PADA PASIEN TUBERKULOSIS SEBELUM DAN SETELAH PENGOBATAN SELAMA 2 BULAN = Analysis of Interleukin-12, Interleukin-4, and CXCL10 Levels in Tuberculosis Patients Before and After 2 Months of Treatment


PUTRI, MUTMAINNA KARTIKA (2026) ANALISIS KADAR INTERLEUKIN-12, INTERLEUKIN-4, CXCL10 PADA PASIEN TUBERKULOSIS SEBELUM DAN SETELAH PENGOBATAN SELAMA 2 BULAN = Analysis of Interleukin-12, Interleukin-4, and CXCL10 Levels in Tuberculosis Patients Before and After 2 Months of Treatment. Thesis thesis, Universitas Hasanuddin.

[thumbnail of P062232024-TXcACtxUjP31Nzsq-20261013174053.pdf] Text
P062232024-TXcACtxUjP31Nzsq-20261013174053.pdf
Restricted to Repository staff only

Download (3MB)

Abstract (Abstrak)

Background. Tuberculosis (TB) remains a major health challenge in high-burden countries such as Indonesia, and conventional clinical evaluation is insufficiently sensitive to detect early immune responses during treatment. Interleukin-12 (IL-12), interleukin-4 (IL-4), and C-X-C motif chemokine ligand 10 (CXCL10) have been proposed as potential immune biomarkers; however, their dynamics during the early treatment phase remain understudied. Objective. This study analyzed changes in IL-12, IL-4, and CXCL10 levels in patients with pulmonary TB during the intensive treatment phase, and their association with ΔBMI, smoking status, and baseline chest X-ray findings. Methods. This prospective cohort study used multistage sampling and enrolled 35 patients with pulmonary TB from five referral primary health centers in Makassar; 21 patients completed follow-up (six deaths and eight losses to follow-up). Serum levels were measured using ELISA at baseline (T0) and week 8 (T1). Differences were analyzed using the paired t-test (IL-12 and IL-4) and Wilcoxon test (CXCL10); correlations were analyzed using Pearson (IL-12 and IL-4) and Spearman (CXCL10) tests. Results. IL-12 decreased significantly from 20.94 to 18.91 pg/mL (p=0.012), and CXCL10 decreased sharply from 25.80 to 21.29 pg/mL (p<0.001), whereas IL-4 showed no significant change (p=0.773). None of the three biomarker deltas correlated with ΔBMI (p>0.05). Smoking status showed a moderate correlation with ΔIL-4 (r=0.561; p=0.008), but not with ΔIL-12 or ΔCXCL10. Baseline chest X-ray findings showed a moderate correlation with ΔCXCL10 (ρ=0.467; p=0.033), but not with ΔIL-12 or ΔIL-4. Conclusion. The decline in IL-12 and CXCL10 levels reflected reduced Th1/IFN-γ pathway activity during the intensive treatment phase, with CXCL10 showing the most consistent and pronounced change. IL-4 levels remained relatively stable and were more strongly influenced by smoking status than by treatment. Simultaneously, the association between CXCL10 and baseline radiological severity strengthens its potential as an early biomarker of treatment response. Latar belakang. Tuberkulosis (TB) masih menjadi tantangan kesehatan utama di negara berbeban tinggi seperti Indonesia, sementara evaluasi klinis konvensional belum cukup peka mendeteksi respons imun dini selama pengobatan. Interleukin-12 (IL-12), interleukin-4 (IL-4), dan C-X-C motif chemokine ligand 10 (CXCL10) diusulkan sebagai biomarker imun potensial, namun dinamikanya pada fase awal terapi belum banyak diteliti. Tujuan. Penelitian ini menganalisis perubahan kadar IL-12, IL-4, dan CXCL10 pada pasien TB paru selama fase intensif terapi, serta hubungannya dengan ΔIMT, status merokok, dan hasil foto toraks baseline. Metode. Penelitian kohort prospektif dengan multistage sampling melibatkan 35 pasien TB paru dari lima Puskesmas rujukan di Makassar; 21 pasien menyelesaikan follow-up (6 meninggal, 8 lost to follow-up). Kadar serum diukur dengan ELISA pada awal (T0) dan minggu ke-8 (T1). Perbedaan dianalisis dengan uji t berpasangan (IL-12, IL-4) dan Wilcoxon (CXCL10); korelasi dianalisis dengan Pearson (IL-12, IL-4) dan Spearman (CXCL10). Hasil. IL-12 menurun signifikan dari 20,94 menjadi 18,91 pg/mL (p=0,012), dan CXCL10 menurun tajam dari 25,80 menjadi 21,29 pg/mL (p<0,001), sedangkan IL-4 tidak berubah bermakna (p=0,773). Tidak ada korelasi antara ketiga Δbiomarker dengan ΔIMT (p>0,05). Status merokok berkorelasi sedang dengan ΔIL-4 (r=0,561; p=0,008), tetapi tidak dengan ΔIL-12 maupun ΔCXCL10. Foto toraks baseline berkorelasi sedang dengan ΔCXCL10 (ρ=0,467; p=0,033), tetapi tidak dengan ΔIL-12 maupun ΔIL-4. Kesimpulan. Penurunan IL-12 dan CXCL10 mencerminkan turunnya aktivitas jalur Th1/IFN-γ seiring fase intensif terapi, dengan CXCL10 menunjukkan perubahan paling konsisten dan besar. IL-4 relatif stabil dan lebih dipengaruhi status merokok dibanding terapi, sementara keterkaitan CXCL10 dengan keparahan radiologis awal memperkuat potensinya sebagai biomarker dini respons terapi.

Item Type: Thesis (Thesis)
Uncontrolled Keywords: Keywords: tuberculosis; interleukin-12; interleukin-4; CXCL10; biomarker; treatment response. Kata Kunci: tuberkulosis; interleukin-12; interleukin-4; CXCL10; biomarker; respon terapi
Subjects: R Medicine > RB Pathology
Divisions (Program Studi): Program Pascasarjana > Ilmu Biomedik
Depositing User: Unnamed user with username pklpkl
Date Deposited: 06 Nov 2026 00:42
Last Modified: 06 Nov 2026 00:42
URI: http://repository.unhas.ac.id:443/id/eprint/61275

Actions (login required)

View Item
View Item